There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cybin (CYBN – Research Report) and Corbus ...

This was the stock's second consecutive day of losses.

Rothwell brings to the clinical-stage biotechnology company more than 25 years of experience as a business leader and as a senior executive in the Canadian capital markets and investment banking, ...